Table 1 The relationship between PUM1 protein levels and clinic characteristics of patients with pancreatic adenocarcinoma

From: PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells

Characteristic

PUM1 level

p-value

High expression n = 39

Low expression n = 21

Age

56.32 ± 1232

59.24 ± 11.48

0.876

Sex

  

0.548

 Male

21

13

 

 Female

18

8

 

Ajcc_T staging

  

0.011

 T1 + T2

29 (74.36)

20 (100)

 

 T3 + T4

10 (25.64)

0 (0)

 

Ajcc_N staging (%)

  

0.034

 N0

23 (58.97)

18 (85.71)

 

 N1 + N2

16 (41.03)

3 (14.29)

 

Ajcc_M staging (%)

  

0.020

 M0

27 (69.23)

20 (95.24)

 

 M1

12 (30.77)

1 (4.76)

 

Ajcc_TNM_stage (%)

  

0.020

 Stage I + II

27 (69.23)

20 (95.24)

 

 Stage III + IV

12 (30.77)

1 (4.76)

 
Back to article page